BCAL Diagnostics Limited

ASX:BDX 주식 보고서

시가총액: AU$37.7m

BCAL Diagnostics 미래 성장

Future 기준 확인 5/6

BCAL Diagnostics is forecast to grow earnings and revenue by 90.6% and 77.6% per annum respectively while EPS is expected to grow by 99.2% per annum.

주요 정보

90.6%

수익 성장률

99.2%

EPS 성장률

Biotechs 수익 성장15.2%
매출 성장률77.6%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트13 Aug 2024

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Is BCAL Diagnostics (ASX:BDX) In A Good Position To Deliver On Growth Plans?

Aug 08
Is BCAL Diagnostics (ASX:BDX) In A Good Position To Deliver On Growth Plans?

Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Apr 07
Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About BCAL Diagnostics' (ASX:BDX) Cash Burn Situation

Dec 23
Here's Why We're Not Too Worried About BCAL Diagnostics' (ASX:BDX) Cash Burn Situation

수익 및 매출 성장 예측

ASX:BDX - 애널리스트의 미래 추정치 및 과거 재무 데이터 (AUD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
6/30/2026124441
6/30/20253-7-7-71
6/30/20243-6-6-5N/A
3/31/20243-6-5-4N/A
12/31/20234-5-5-4N/A
9/30/20233-5-6-5N/A
6/30/20233-5-6-6N/A
3/31/20232-5-6-5N/A
12/31/20221-5-5-5N/A
9/30/20221-4-4-4N/A
6/30/20221-3-3-3N/A
3/31/20221-3-3-3N/A
12/31/20211-3-3-3N/A
9/30/20210-2-2-2N/A
6/30/20210-2-1-1N/A
3/31/20210-1-1-1N/A
12/31/20201000N/A
9/30/20200-100N/A
6/30/20200-1-1-1N/A
6/30/201900-1-1N/A
6/30/20180000N/A

애널리스트 미래 성장 예측

수입 대 저축률: BDX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).

수익 vs 시장: BDX is forecast to become profitable over the next 3 years, which is considered above average market growth.

고성장 수익: BDX is expected to become profitable in the next 3 years.

수익 대 시장: BDX's revenue (77.6% per year) is forecast to grow faster than the Australian market (5.7% per year).

고성장 수익: BDX's revenue (77.6% per year) is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if BDX's Return on Equity is forecast to be high in 3 years time


성장 기업 발견